These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4293744)

  • 1. Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection.
    Gutekunst RR; White RJ; Edmondson WP; Chanock RM
    Am J Epidemiol; 1967 Sep; 86(2):341-9. PubMed ID: 4293744
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.
    Top FH; Buescher EL; Bancroft WH; Russell PK
    J Infect Dis; 1971 Aug; 124(2):155-60. PubMed ID: 4330998
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous oral administration of live adenovirus types 4 and 7 vaccines. Protection and lack of emergence of other types.
    Gooch WM; Mogabgab WJ
    Arch Environ Health; 1972 Dec; 25(6):388-94. PubMed ID: 4343867
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans.
    Top FH; Grossman RA; Bartelloni PJ; Segal HE; Dudding BA; Russell PK; Buescher EL
    J Infect Dis; 1971 Aug; 124(2):148-54. PubMed ID: 4330997
    [No Abstract]   [Full Text] [Related]  

  • 5. Enteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers.
    Dudding BA; Bartelloni PJ; Scott RM; Top FH; Russell PK; Buescher EL
    Infect Immun; 1972 Mar; 5(3):295-9. PubMed ID: 4564559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent experiences with live adenovirus vaccines in navy recruits.
    Rosenbaum MJ; Edwards EA; Hoeffler DF CAPT
    Mil Med; 1975 Apr; 140(4):251-7. PubMed ID: 167324
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: clinical and immunological responses.
    Smith TJ; Buescher EL; Top FH; Altemeier WA; McCown JM
    J Infect Dis; 1970 Oct; 122(4):239-48. PubMed ID: 4323443
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of live, oral types 1, 2, and 5 adenovirus vaccines.
    Schwartz AR; Togo Y; Hornick RB
    Am Rev Respir Dis; 1974 Feb; 109(2):233-9. PubMed ID: 4359736
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
    van der Veen J; Abarbanel MF; Oei KG
    Antonie Van Leeuwenhoek; 1969; 35(2):239. PubMed ID: 4316421
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunization of Canadian Armed Forces personnel with live types 4 and 7 adenovirus vaccines.
    Chaloner-Larsson G; Contreras G; Furesz J; Boucher DW; Krepps D; Humphreys GR; Mohanna SM
    Can J Public Health; 1986; 77(5):367-70. PubMed ID: 3024797
    [No Abstract]   [Full Text] [Related]  

  • 11. Live and inactivated adenovirus vaccines for the prevention of acute respiratory illness in naval recruits.
    Pierce WE; Rosenbaum MJ; Edwards EA; Peckinpaugh RO; Jackson GG
    Am J Epidemiol; 1968 Jan; 87(1):237-46. PubMed ID: 4295428
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
    van der Veen J; Abarbanel MF; Oei KG
    J Hyg (Lond); 1968 Dec; 66(4):499-511. PubMed ID: 4303951
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. specific protective effect against epidemic disease.
    Edmondson WP; Purcell RH; Gundelfinger BF; Love JW; Ludwig W; Chanock RM
    JAMA; 1966 Feb; 195(6):453-9. PubMed ID: 4285433
    [No Abstract]   [Full Text] [Related]  

  • 14. A subunit vaccine against hemorrhagic enteritis adenovirus.
    Pitcovski J; Fingerut E; Gallili G; Eliahu D; Finger A; Gutter B
    Vaccine; 2005 Sep; 23(38):4697-702. PubMed ID: 15998555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus vaccines in the U.S. military.
    Gaydos CA; Gaydos JC
    Mil Med; 1995 Jun; 160(6):300-4. PubMed ID: 7659229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines.
    Top FH; Dudding BA; Russell PK; Buescher EL
    Am J Epidemiol; 1971 Aug; 94(2):142-6. PubMed ID: 4327997
    [No Abstract]   [Full Text] [Related]  

  • 17. Mass enteric live adenovirus vaccination during epidemic ARD.
    Peckinpaugh RO; Pierce WE; Rosenbaum MJ; Edwards EA; Jackson GG
    JAMA; 1968 Jul; 205(1):75-80. PubMed ID: 4298134
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers.
    Chanock RM; Ludwig W; Heubner RJ; Cate TR; Chu LW
    JAMA; 1966 Feb; 195(6):445-52. PubMed ID: 4296283
    [No Abstract]   [Full Text] [Related]  

  • 19. Live and killed adenovirus vaccines for the prevention of acute respiratory disease in recruits.
    Pierce WE; Peckinpaugh RO; Frazier WE; Griffin JP; Greenberg BH; Jackson GG
    Antimicrob Agents Chemother (Bethesda); 1965; 5():55-8. PubMed ID: 4286921
    [No Abstract]   [Full Text] [Related]  

  • 20. Current use and future directions of adenovirus vaccine.
    Gurwith MJ; Horwith GS; Impellizzeri CA; Davis AR; Lubeck MD; Hung PP
    Semin Respir Infect; 1989 Dec; 4(4):299-303. PubMed ID: 2560582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.